In these populations, GLP-1 medications may: Suppress appetite in ways that destabilize recovery Mask symptoms without addressing underlying drivers Increase psychological distress related to food, weight, or control Any consideration of GLP-1 use should involve careful medical oversight, psychological evaluation, and ongoing monitoring
Animal studies have documented significant improvements in Morris water maze performance, radial arm maze accuracy, and novel object recognition tasks, with effects persisting for extended periods after treatment suggesting lasting changes in neural connectivity rather than temporary pharmacological stimulation
If in doubt, please consult with your doctor or healthcare provider
Effect of chronic smoking on lipid peroxidation and antioxidant status in gastric carcinoma patients
Meaningful weight loss emerges by week 34 in most patients following proper dose escalation with PlexusDx protocols
if anything, tolerability concerns argue for going slower